Star Combo Pharma Limited (ASX:S66)

Market Cap	17.56M -18.8%
Revenue (ttm)	23.99M -18.8%
Net Income	4.12M +499.8%
EPS	0.03 +369.9%
Shares Out	135.08M
PE Ratio	4.26
Forward PE	n/a
Dividend	0.00 (2.85%)
Ex-Dividend Date	Oct 14, 2025

Volume	102,538
Open	0.1300
Previous Close	0.1300
Day's Range	0.1300 - 0.1300
52-Week Range	0.1100 - 0.2750
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Star Combo Pharma

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2004
• Employees: 30
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: S66

Financial Performance

In fiscal year 2025, Star Combo Pharma's revenue was 27.81 million, an increase of 6.89% compared to the previous year's 26.02 million. Earnings were 3.98 million, an increase of 432.73%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 11, 2026

Data Sources Report a data error